DENTSPLY SIRONA Inc. XRAY
Set alert
9.90 USD +0.37 +3.88%
At close
9.93 +0.03 +0.30%
Pre-market · Nov 3, 7:05 AM ET
9.62 Day range 9.96
8.32 52-week range 14.76
- YTD
- -13.39%
- 1 year
- -21.49%
- Open
- 9.65
- Prev close
- 9.53
- Mkt cap
- 1.97B
- Vol
- 6.06M
- Avg vol
- 4.52M
- EPS
- -2.73
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 9.62
- High
- 9.96
- Forward P/E
- 6.70
- Beta
- 0.86
- Short ratio
- 5.59
- Inst. own
- 116.59%
- Dividend
- 0.00
- Ex-div date
- Dec 25, 2025
- Earnings
- Nov 5, 2026
- 50-d avg
- 9.70
- 200-d avg
- 11.33
- 1y target
- 12.40
6M chart
Events in this range
- May 5, 2026Earnings: 0.27; estimate 0.28; surprise -3.57%
- Aug 6, 2026Earnings: 0.52; estimate 0.348; surprise 49.43%
- Aug 24, 2026Rating: Barclays · Underweight → Underweight
- Sep 17, 2026Rating: BMO Capital · Market Perform → Market Perform
- Oct 9, 2026Rating: Piper Sandler · Neutral → Neutral
- Oct 14, 2026Rating: Leerink Partners · Market Perform → Market Perform
- Oct 22, 2026Rating: Mizuho · Neutral → Neutral
- Oct 26, 2026Rating: Barrington Research · Outperform → Outperform
Signals (26)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Nov 2, 2026 | 22 hours ago |
| RSI: Oversold | Oct 14, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 9, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 30, 2026 | 1 month ago |
| RSI: Oversold | Sep 17, 2026 | 1 month ago |
| RSI: Oversold | Sep 15, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 11, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 2, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 13, 2026 | 2 months ago |
| SMA: Bearish | Aug 12, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 5, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 31, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 29, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 24, 2026 | 3 months ago |
| RSI: Overbought | Jul 15, 2026 | 3 months ago |
| RSI: Overbought | Jul 13, 2026 | 3 months ago |
| RSI: Overbought | Jul 6, 2026 | 3 months ago |
Newest 20 of 26.
Analyst view
Consensus: hold
Hold
Price target (mean) 12.40 +25.3% upside
Now 9.90
- Target (low)
- 9.00
- Target (mean)
- 12.40
- Target (high)
- 17.00
Ratings (0m) 17 4 buy · 12 hold · 1 sell
- Strong buy2
- Buy2
- Hold12
- Sell0
- Strong sell1
Recommendation trend
- This month 17
- 1 month ago 17
- 2 months ago 18
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.30931 | 0.26 – 0.34 | 0.37 | -16.4% | 861.65M | -4.7% | 16 |
| Next quarter | 0.45203 | 0.34 – 0.53597 | 0.27 | +67.4% | 933.98M | -2.8% | 16 |
| Current year | 1.49 | 1.28 – 1.60 | 1.60 | -6.9% | 3.57B | -3.0% | 17 |
| Next year | 1.48 | 1.36 – 1.65 | 1.49 | -0.8% | 3.61B | +1.2% | 17 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 26, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Oct 22, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Oct 14, 2026 | Leerink Partners | Maintained | Market Perform | Market Perform |
| Oct 9, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| Sep 17, 2026 | BMO Capital | Maintained | Market Perform | Market Perform |
| Aug 24, 2026 | Barclays | Maintained | Underweight | Underweight |
| Jul 29, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| Jul 9, 2026 | BMO Capital | Initiated | — | Market Perform |
| Jun 4, 2026 | Barclays | Maintained | Underweight | Underweight |
| May 7, 2026 | UBS | Maintained | Buy | Buy |
| May 6, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Apr 15, 2026 | Citigroup | Initiated | — | Sell |
| Mar 2, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Mar 2, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Feb 27, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Feb 27, 2026 | Evercore ISI Group | Maintained | In-Line | In-Line |
| Feb 27, 2026 | Baird | Maintained | Neutral | Neutral |
| Feb 19, 2026 | B of A Securities | Upgrade | Neutral | Buy |
| Feb 3, 2026 | UBS | Maintained | Buy | Buy |
| Jan 20, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Jan 5, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Dec 16, 2025 | Barrington Research | Maintained | Outperform | Outperform |
| Dec 16, 2025 | Baird | Maintained | Neutral | Neutral |
| Dec 9, 2025 | Barclays | Initiated | — | Underweight |
| Nov 10, 2025 | Barrington Research | Maintained | Outperform | Outperform |
| Nov 7, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| Nov 7, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Nov 7, 2025 | William Blair | Downgrade | Outperform | Market Perform |
| Oct 29, 2025 | Barrington Research | Maintained | Outperform | Outperform |
| Oct 28, 2025 | UBS | Maintained | Buy | Buy |